The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Xylooligosaccharide supplementation alters gut bacteria in both healthy and prediabetic adults: a pilot study
Open accessAbstract
BACKGROUND: It has been suggested that gut microbiota is altered in Type 2 Diabetes Mellitus (T2DM) patients. OBJECTIVE: This study was to evaluate the effect of the prebiotic xylooligosaccharide (XOS) on the gut microbiota in both healthy and prediabetic (Pre-DM) subjects, as well as impaired glucose tolerance (IGT) in Pre-DM. SUBJECTS/METHODS: Pre-DM (n = 13) or healthy (n = 16) subjects were randomized to receive 2 g/day XOS or placebo for 8-weeks. In Pre-DM subjects, body composition and oral glucose tolerance test (OGTT) was done at baseline and week 8. Stool from Pre-DM and healthy subjects at baseline and week 8 was analyzed for gut microbiota characterization using Illumina MiSeq sequencing. RESULTS: We identified 40 Pre-DM associated bacterial taxa. Among them, the abundance of the genera Enterorhabdus, Howardella, and Slackia was higher in Pre-DM. XOS significantly decreased or reversed the increase in abundance of Howardella, Enterorhabdus, and Slackia observed in healthy or Pre-DM subjects. Abundance of the species Blautia hydrogenotrophica was lower in pre-DM subjects, while XOS increased its abundance. In Pre-DM, XOS showed a tendency to reduce OGTT 2-h insulin levels (P = 0.13), but had no effect on body composition, HOMA-IR, serum glucose, triglyceride, satiety hormones, and TNFα. CONCLUSION: This is the first clinical observation of modifications of the gut microbiota by XOS in both healthy and Pre-DM subjects in a pilot study. Prebiotic XOS may be beneficial in reversing changes in the gut microbiota during the development of diabetes. CLINICAL TRIAL REGISTRATION: NCT01944904 (https://clinicaltrials.gov/ct2/show/NCT01944904).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB
DeSantis, T. Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E. L., Keller, K., Huber, T., Dalevi, D., Hu, P., & Andersen, G. L. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.03006-05 · Cited by 10,891
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Self-citationStandards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009085 · Cited by 2,952 · cited 4×
“The Bacteroidetes/Firmicutes ratio is associated with increased plasma glucose concentrations and a decrease in butyrate-producing bacteria in T2DM patients (Larsen et al., 2010; Shen et al., 2013).”
BackgroundInfluentialDysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives
Joossens, M., Huys, G., Cnockaert, M., De Preter, V., Verbeke, K., Rutgeerts, P., Vandamme, P., & Vermeire, S. (2011) · Gut · doi:10.1136/gut.2010.223263 · Cited by 1,063
Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children
Kang, D.-W., Park, J. G., Ilhan, Z. E., Wallstrom, G., LaBaer, J., Adams, J. B., & Krajmalnik-Brown, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068322 · Cited by 976 · cited 2×
“Frontiers in Physiology | www.frontiersin.org 4 August 2015 | Volume 6 | Article 216”
BackgroundHuman Gut Microbiota Changes Reveal the Progression of Glucose Intolerance
Zhang, X., Shen, D., Fang, Z., Jie, Z., Qiu, X., Zhang, C., Chen, Y., & Ji, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071108 · Cited by 946 · cited 5×
“Furthermore, in healthy subjects, XOS greatly reduced the abundance of bacteria related to obesity or T2DM, including phylum Firmicutes and genera Subdoligranulum and Bacilli (Remely et al., 2013; Zhang et al., 2013).”
BackgroundInfluentialGut microbiome composition is linked to whole grain-induced immunological improvements
Martínez, I., Lattimer, J. M., Hubach, K. L., Case, J. A., Yang, J., Weber, C. G., Louk, J. A., Rose, D. J., Kyureghian, G., Peterson, D. A., et al. (2013) · The ISME Journal · doi:10.1038/ismej.2012.104 · Cited by 614 · cited 1×
“Dietary whole grain intervention (Martinez et al., 2013) and corn fiber (Hooda et al., 2012) increased the Dialister and Veillonellaceae abundance.”
BackgroundSelf-citationInteractions Between Gut Microbiota and Host Metabolism Predisposing to Obesity and Diabetes
Musso, G., Gambino, R., & Cassader, M. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-012510-175505 · Cited by 598
Microbiota conservation and BMI signatures in adult monozygotic twins
Tims, S., Derom, C., Jonkers, D. M., Vlietinck, R., Saris, W. H., Kleerebezem, M., de Vos, W. M., & Zoetendal, E. G. (2013) · The ISME Journal · doi:10.1038/ismej.2012.146 · Cited by 367
Xylooligosaccharide increases bifidobacteria but not lactobacilli in human gut microbiota
Finegold, S. M., Li, Z., Summanen, P. H., Downes, J., Thames, G., Corbett, K., Dowd, S., Krak, M., & Heber, D. (2014) · Food & Function · doi:10.1039/c3fo60348b · Cited by 255
Self-citationEsteve, E., Ricart, W., & Fernández-Real, J.-M. (2011) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328348c06d · Cited by 133
Hsueh, W., McLellan, K., Wyne, K., & Villagomez, E. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s39564 · Cited by 91 · cited 3×
“Pre-DM is characterized by glucose dysregulation and a higher risk of developing T2DM and other associated complications (Portero McLellan et al., 2014).”
BackgroundInfluential
Cited by
From lignocellulosic residues to market: Production and commercial potential of xylooligosaccharides
Amorim, C., Silvério, S. C., Prather, K. L. J., & Rodrigues, L. R. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.05.003 · Cited by 277
Palaniappan, A., Antony, U., & Emmambux, M. N. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.02.047 · Cited by 202
Zhao, C., Yang, C., Wai, S. T. C., Zhang, Y., P. Portillo, M., Paoli, P., Wu, Y., San Cheang, W., Liu, B., Carpéné, C., et al. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1501658 · Cited by 199
Recent Advances in the Enzymatic Production and Applications of Xylooligosaccharides
Capetti, C. C. D. M., Vacilotto, M. M., Dabul, A. N. G., Sepulchro, A. G. V., Pellegrini, V. O. A., & Polikarpov, I. (2021) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-021-03139-7 · Cited by 63
Metadata
- Authors
- Yang, J., Summanen, P. H., Henning, S. M., Hsu, M., Lam, H., Huang, J., Tseng, C.-H., Dowd, S. E., Finegold, S. M., Heber, D., & Li, Z.
- Venue
- Frontiers in Physiology
- Publisher
- Frontiers Media SA
- Published
- 2015-08-07
- Volume
- 6
- Pages
- 216-216
- ISSN
- 1664-042X (ISSN-L)
- OpenAlex
- W1589649796
- Cited by
- 168
- References
- 13
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.